Baxter International Inc (BAX) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment at this time. The stock is in a bearish trend with no significant positive catalysts, weak financial performance, and neutral trading sentiment. Analysts have lowered price targets, and there are no recent signals from Intellectia Proprietary Trading Signals to suggest a strong buy opportunity.
The stock is in a bearish trend with MACD negatively expanding (-0.31), RSI at 20.911 indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The price is near a key support level (S1: 18.812), but the overall trend remains negative.

NULL identified. There is no recent news or significant insider or hedge fund activity to act as a positive catalyst.
Analysts have consistently lowered price targets, citing weak financial performance, margin pressures, and underwhelming 2026 guidance. The company's gross margin dropped significantly (-45.16% YoY), and net income remains negative.
In Q4 2025, revenue increased 8.03% YoY to $2.97B, but net income was -$1.13B, up 120.31% YoY. EPS improved to -2.2, but gross margin fell to 20.24%, down 45.16% YoY. The financials indicate growth in revenue but significant profitability challenges.
Analysts have a neutral to bearish stance on the stock. Multiple firms, including Goldman Sachs, UBS, and Deutsche Bank, have lowered price targets, citing weak financial performance and limited near-term visibility. The average price target is below the current price, reflecting a lack of confidence in the stock's upside potential.